Terms: = Breast cancer AND FOXO3, FKHRL1, 2309, ENSG00000118689, MGC31925, MGC12739, FOXO2, FOXO3A, O43524, AF6q21, FKHRL1P2, DKFZp781A0677 AND Prognosis
26 results:
1. Molecular Pathology of Micropapillary Carcinomas: Is Characteristic Morphology Related to Molecular Mechanisms?
Sagnak Yilmaz Z; Sarioglu S
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):267-277. PubMed ID: 37036419
[TBL] [Abstract] [Full Text] [Related]
2. Could be foxo3a, miR-96-5p and miR-182-5p useful for Brazilian women with luminal A and triple negative breast cancers prognosis and target therapy?
Mendes DCC; Filho CMCC; Garcia N; Ricci MD; Soares JM; Carvalho KC; Baracat EC
Clinics (Sao Paulo); 2023; 78():100155. PubMed ID: 36681070
[TBL] [Abstract] [Full Text] [Related]
3. The Pan-cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug Resistance.
Xie J; Zhang J; Tian W; Zou Y; Tang Y; Zheng S; Wong CW; Deng X; Wu S; Chen J; Mo Y; Xie X
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555288
[TBL] [Abstract] [Full Text] [Related]
4. Incorporating immunohistochemical markers into screening methods for BRCA1-mutated breast cancer.
Tuzimek A; Fudalej M; Sobiborowicz A; Budzik M; Badowska-Kozakiewicz A
Pol J Pathol; 2020; 71(3):261-269. PubMed ID: 33112117
[TBL] [Abstract] [Full Text] [Related]
5. MiR-940 promotes malignant progression of breast cancer by regulating foxo3.
Zhang H; Peng J; Lai J; Liu H; Zhang Z; Li X; Liang B; Chen X; Zou B; Lin S; Zhang L
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32840296
[TBL] [Abstract] [Full Text] [Related]
6. The high protein expression of foxo3, but not that of FOXO1, is associated with markers of good prognosis.
Lallemand F; Vacher S; de Koning L; Petitalot A; Briaux A; Driouch K; Callens C; Schnitzler A; Lecerf C; Oulie-Bard F; Barbet A; Vincent A; Zinn-Justin S; Lopez BS; Lidereau R; Bieche I; Caputo SM
Sci Rep; 2020 Apr; 10(1):6920. PubMed ID: 32332845
[TBL] [Abstract] [Full Text] [Related]
7. Inflammatory macrophage derived TNFα downregulates estrogen receptor α via foxo3a inactivation in human breast cancer cells.
Gunnarsdóttir FB; Hagerling C; Bergenfelz C; Mehmeti M; Källberg E; Allaoui R; Mohlin S; Påhlman S; Larsson C; Jirström K; Bexell D; Leandersson K
Exp Cell Res; 2020 May; 390(1):111932. PubMed ID: 32145253
[TBL] [Abstract] [Full Text] [Related]
8. Pathway Mutations in breast cancer Using Whole-Exome Sequencing.
Chang YS; Chang CM; Lin CY; Chao DS; Huang HY; Chang JG
Oncol Res; 2020 Mar; 28(2):107-116. PubMed ID: 31575382
[TBL] [Abstract] [Full Text] [Related]
9. Downregulation of foxo3a by DNMT1 promotes breast cancer stem cell properties and tumorigenesis.
Liu H; Song Y; Qiu H; Liu Y; Luo K; Yi Y; Jiang G; Lu M; Zhang Z; Yin J; Zeng S; Chen X; Deng M; Jia X; Gu Y; Chen D; Zheng G; He Z
Cell Death Differ; 2020 Mar; 27(3):966-983. PubMed ID: 31296961
[TBL] [Abstract] [Full Text] [Related]
10. Promyelocytic leukemia protein (PML) controls breast cancer cell proliferation by modulating Forkhead transcription factors.
Sachini N; Arampatzi P; Klonizakis A; Nikolaou C; Makatounakis T; Lam EW; Kretsovali A; Papamatheakis J
Mol Oncol; 2019 Jun; 13(6):1369-1387. PubMed ID: 30927552
[TBL] [Abstract] [Full Text] [Related]
11. Neddylation Inactivation Facilitates foxo3a Nuclear Export to Suppress Estrogen Receptor Transcription and Improve Fulvestrant Sensitivity.
Jia X; Li C; Li L; Liu X; Zhou L; Zhang W; Ni S; Lu Y; Chen L; Jeong LS; Yu J; Zhang Y; Zhang J; He S; Hu X; Sun H; Yu K; Liu G; Zhao H; Zhang Y; Jia L; Shao ZM
Clin Cancer Res; 2019 Jun; 25(12):3658-3672. PubMed ID: 30833270
[TBL] [Abstract] [Full Text] [Related]
12. Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced breast cancer Stem Cell Enrichment.
Lu H; Tran L; Park Y; Chen I; Lan J; Xie Y; Semenza GL
Cancer Res; 2018 Aug; 78(15):4191-4202. PubMed ID: 29880481
[TBL] [Abstract] [Full Text] [Related]
13. miR-182-5p promotes hepatocellular carcinoma progression by repressing foxo3a.
Cao MQ; You AB; Zhu XD; Zhang W; Zhang YY; Zhang SZ; Zhang KW; Cai H; Shi WK; Li XL; Li KS; Gao DM; Ma DN; Ye BG; Wang CH; Qin CD; Sun HC; Zhang T; Tang ZY
J Hematol Oncol; 2018 Jan; 11(1):12. PubMed ID: 29361949
[TBL] [Abstract] [Full Text] [Related]
14. Unravelling the role of fatty acid metabolism in cancer through the foxo3-FOXM1 axis.
Saavedra-García P; Nichols K; Mahmud Z; Fan LY; Lam EW
Mol Cell Endocrinol; 2018 Feb; 462(Pt B):82-92. PubMed ID: 28087388
[TBL] [Abstract] [Full Text] [Related]
15. High expression of EPB41L5, an integral component of the Arf6-driven mesenchymal program, correlates with poor prognosis of squamous cell carcinoma of the tongue.
Otsuka Y; Sato H; Oikawa T; Onodera Y; Nam JM; Hashimoto A; Fukunaga K; Hatanaka KC; Hatanaka Y; Matsuno Y; Fukuda S; Sabe H
Cell Commun Signal; 2016 Nov; 14(1):28. PubMed ID: 27871329
[TBL] [Abstract] [Full Text] [Related]
16. Expression of FOXM1 and related proteins in breast cancer molecular subtypes.
Lee JJ; Lee HJ; Son BH; Kim SB; Ahn JH; Ahn SD; Cho EY; Gong G
Int J Exp Pathol; 2016 Apr; 97(2):170-7. PubMed ID: 27277416
[TBL] [Abstract] [Full Text] [Related]
17. TIMP4 Modulates ER-α Signalling in MCF7 breast cancer Cells.
Pruefer F; Vazquez-Santillan K; Munoz-Galindo L; Cruz-Colin JL; Maldonado V; Melendez-Zajgla J
Folia Biol (Praha); 2016; 62(2):75-81. PubMed ID: 27187039
[TBL] [Abstract] [Full Text] [Related]
18. Analysis of expression of PTEN/PI3K pathway and programmed cell death ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM).
Cedrés S; Ponce-Aix S; Pardo-Aranda N; Navarro-Mendivil A; Martinez-Marti A; Zugazagoitia J; Sansano I; Montoro MA; Enguita A; Felip E
Lung Cancer; 2016 Jun; 96():1-6. PubMed ID: 27133741
[TBL] [Abstract] [Full Text] [Related]
19. hMENA(11a) contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells.
Trono P; Di Modugno F; Circo R; Spada S; Di Benedetto A; Melchionna R; Palermo B; Matteoni S; Soddu S; Mottolese M; De Maria R; Nisticò P
Oncogene; 2016 Feb; 35(7):887-96. PubMed ID: 25961924
[TBL] [Abstract] [Full Text] [Related]
20. Increased expression of forkhead box M1 is associated with aggressive phenotype and poor prognosis in estrogen receptor-positive breast cancer.
Ahn H; Sim J; Abdul R; Chung MS; Paik SS; Oh YH; Park CK; Jang K
J Korean Med Sci; 2015 Apr; 30(4):390-7. PubMed ID: 25829806
[TBL] [Abstract] [Full Text] [Related]
[Next]